pharmacie et médicaments – Baisse du plafond des remises des laboratoires sur les médicaments

This written question concerns the potential reduction of the maximum rebates that pharmaceutical laboratories can receive on medicines. It seeks clarification on the implications of such a policy change. The question addresses the impact on the pharmaceutical industry and potentially on drug pricing and availability for patients. It is directed towards government ministers for a response.